Running as good as antidepressants for mental health benefits, and a winner in physical health

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-10-09 04:15 GMT   |   Update On 2023-10-09 04:15 GMT

A recent study comparing the effects of running exercises and antidepressants for the treatment of anxiety, depression, and overall health reveals that both approaches yield similar benefits for mental health. However, a 16-week running regimen outperforms antidepressants in terms of improving physical health, while the medication group experiences a slight decline in physical condition.The...

Login or Register to read the full article

A recent study comparing the effects of running exercises and antidepressants for the treatment of anxiety, depression, and overall health reveals that both approaches yield similar benefits for mental health. However, a 16-week running regimen outperforms antidepressants in terms of improving physical health, while the medication group experiences a slight decline in physical condition.

The study involved 141 patients grappling with depression and/or anxiety, who were offered the choice between a 16-week course of SSRI antidepressants or group-based running therapy. Of these, 45 individuals opted for antidepressants, while 96 chose running.

Treatment with antidepressants involved adhering to a prescribed medication regimen, with minimal direct impact on daily behaviors. In contrast, exercise addressed the sedentary lifestyle often observed in patients with depressive and anxiety disorders, promoting outdoor activity, goal setting, fitness improvement, and group participation.

The antidepressant group received the SSRI Escitalopram for 16 weeks, while the running group aimed for two to three closely supervised 45-minute group sessions per week over the same period.

At the end of the trial, approximately 44% of participants in both groups showed improvements in depression and anxiety symptoms. However, the running group also demonstrated enhancements in weight, waist circumference, blood pressure, and heart function. Conversely, the antidepressant group exhibited a slight tendency toward deterioration in these metabolic markers.

Reference: European College of Neuropsychopharmacology

Meeting: 36th European College of Neuropsychopharmacology (ECNP) conference

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News